Do TPO and thyroglobulin antibodies reflect immune loss of tolerance and associate with systemic low-grade inflammation?

Thyroid autoimmunity, characterized by the presence of thyroid peroxidase antibodies (TPOAb) and thyroglobulin antibodies (TgAb), is an established indicator of the immune system’s failure to maintain self-tolerance. This immune dysregulation frequently coincides with systemic low-grade inflammation, measurable through biomarkers like high-sensitivity C-reactive protein (hs-CRP).

Clinical and mechanistic findings

• Loss of immune tolerance: The presence of TPOAb and TgAb signifies a breakdown in central and peripheral tolerance mechanisms. Mechanistically, this is driven by the dysfunction of T-regulatory (Treg) cells (CD4+CD25+FoxP3+), which normally suppress autoreactive T and B cells. In older individuals, immunosenescence and gut dysbiosis can further impair dendritic cell function, leading to a shift from tolerance to pro-inflammatory T-cell responses against thyroid antigens.
• Systemic inflammation (hs-CRP): Thyroid autoimmunity often correlates with systemic inflammatory markers. In studies of subclinical hypothyroidism (SCH), TPOAb levels show a significant positive correlation with hs-CRP (r = 0.58, p < 0.001). Patients with elevated antibodies frequently exhibit higher hs-CRP alongside metabolic disruptions such as dyslipidemia and increased oxidative stress.
• Role of oxidative stress: The autoimmune process in the thyroid is intrinsically linked to oxidative pathways. Research indicates that interventions such as selenium supplementation can reduce TPOAb titers by mitigating oxidative stress, suggesting that the localized thyroid autoimmune response contributes to or reflects a broader systemic inflammatory state.

Limitations and considerations

While the association between thyroid antibodies and hs-CRP is robust in hypothyroid and subclinical populations, the evidence is less definitive for euthyroid individuals (those with normal TSH). Furthermore, since most thyroid research focuses on female populations, data specifically for males often relies on extrapolated mechanistic similarities regarding Treg dysfunction and age-related chronic inflammation.

Bottom line

Thyroid autoantibodies are clear markers of immune tolerance loss, and their presence is plausibly linked to systemic low-grade inflammation. This relationship is particularly evident in subclinical hypothyroidism, where elevated hs-CRP serves as a concurrent marker of autoimmune activity and associated metabolic risk.